| Autor: |
Jitendra PS. Sawhney, Sivasubramanian Ramakrishnan, Kushal Madan, Saumitra Ray, P Balagopalan Jayagopal, Dorairaj Prabhakaran, Tiny Nair, Geevar Zachariah, Peeyush Jain, Jamshed Dalal, Sitaraman Radhakrishnan, Arun Chopra, Sanjay Kalra, Ashwani Mehta, Arvind K. Pancholia, Nitin K. Kabra, Dhiman Kahali, Tapan Ghose, Satyavir Yadav, Prafulla Kerkar, Ajay Yadav, Debabrata Roy, Mrinal Kanti Das, Vijay H. Bang, Pratap Chandra Rath, Dhurjati Prasad Sinha, P.S. Banerjee, Rakesh Yadav, Rajeev Gupta |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
Indian Heart Journal, Vol 76, Iss , Pp S6-S19 (2024) |
| Druh dokumentu: |
article |
| ISSN: |
0019-4832 |
| DOI: |
10.1016/j.ihj.2023.11.271 |
| Popis: |
Dyslipidemias are the most important coronary artery disease (CAD) risk factor. Proper management of dyslipidemia is crucial to control the epidemic of premature CAD in India. Cardiological Society of India strived to develop consensus-based guidelines for better lipid management for CAD prevention and treatment. The executive summary provides a bird's eye-view of the ‘CSI: Clinical Practice Guidelines for Dyslipidemia Management’ published in this issue of the Indian Heart Journal. The summary is focused on the busy clinician and encourages evidence-based management of patients and high-risk individuals. The summary has serialized various aspects of lipid management including epidemiology and categorization of CAD risk. The focus is on management of specific dyslipidemias relevant to India-raised low density lipoprotein (LDL) cholesterol, non-high density lipoprotein cholesterol (non-HDL-C), apolipoproteins, triglycerides and lipoprotein(a). Drug therapies for lipid lowering (statins, non-statin drugs and other pharmaceutical agents) and lifestyle management (dietary interventions, physical activity and yoga) are summarized. Management of dyslipidemias in oft-neglected patient phenotypes-the elderly, young and children, and patients with comorbidities-stroke, peripheral arterial disease, kidney failure, posttransplant, HIV (Human immunodeficiency virus), Covid-19 and familial hypercholesterolemia is also presented. This consensus statement is based on major international guidelines (mainly European) and expert opinion of lipid management leaders from India with focus on the dictum: earlier the better, lower the better, longer the better and together the better. These consensus guidelines cannot replace the individual clinician judgement who remains the sole arbiter in management of the patient. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
